Commitment to ESG Principles

How can pharmaceutical and biopharmaceutical companies demonstrate their commitment to ESG principles in manufacturing?

Pharma's Almanac

Accelerating Product Development

What strategies are being employed to accelerate product development and commercialization without compromising quality?

Pharma's Almanac

Roundtable

What do you see as the most significant regulatory decision or guidance on the horizon for 2024 (or beyond)?

Pharma's Almanac

Roundtable

What Do You Think Was The Single Most Consequential Event Or Result In Pharma/Biopharma In 2023?

Pharma's Almanac

International Markets

In what international markets do you anticipate significant developments in the near future?

Pharma's Almanac

Disruptive Technology

What do you view as the most disruptive or transformational technology or development on the horizon?

Pharma's Almanac

Custom Lipid Nanoparticle Development

The Value of a Custom Lipid Solutions Provider for mRNA Delivery

Lauren Longobardi, Ph.D.; Rima Jaber, Ph.D.; Sebastian Detlefsen, Dr.-Ing.

Evonik

Future of the Industry

What key indicators do you look at to predict the future of this industry?

Pharma's Almanac

Sustainability

What is your plan to build a more sustainable business practice in the coming years?

Pharma's Almanac

mRNA Delivery

New Polymer-Lipid Delivery System for mRNA

Andrea Engel, Ph.D.; Philipp Heller, Ph.D.

Evonik

Leadership

Q: What’s the key to being a leader in the industry?

Pharma's Almanac

Milestones

Q: What important company milestone do you anticipate reaching in 2022?

Pharma's Almanac

Parenteral Drug Delivery

Innovating at the Forefront of mRNA LNP Therapies

Evonik Industries

Personalized and Precision Medicine

Q: What do you see as the key innovations or technologies that will make personalized/precision medicine a reality?

Pharma's Almanac

Therapeutic Progress

Q: For what therapeutic area do you think we will see the greatest progress in the coming years?

Pharma's Almanac

Lipid Nanoparticles

Leveraging True Expertise and Flexibility for Lipid Nanoparticle Clinical Manufacturing

Cole Byvelds, P.Eng.; Kristina Parrant

Evonik

Parenteral Manufacturing

Focus on Commercial Parenteral Manufacturing at Evonik

Caroline Hand; Maaike Everts, Ph.D.

Evonik

Lipid Nanoparticles

Advancing Novel Therapeutics with End-to-End Lipid Nanoparticle Development and Manufacturing

Natalia Zisman

Evonik

Drug Supply

Innovation Pharmaceuticals Signs Drug Supply Contract with Evonik to Bulk Produce Commercial-Grade Brilacidin

Evonik